The main components of "Novopassit" are such medicinal plants as hops, hawthorn, Hypericum, Melissa, black elderberry, passion flower, Valerian and guaifenesin – soothing-natural substance extracted from the bark of the guaiac tree. The complex of these substances in combination has a strong sedative and antianxiety effect, reducing stress reactions and mental tension, and relaxing the smooth muscles.
The drug is prescribed for mild forms of neurasthenia, irritability, constant fatigue, fear, anxiety and panic attacks, memory disorders, insomnia and distraction. In addition, "Novopassit" has proven itself in vascular and neurocirculatory dystonia, neurotic disorders in the elderly, constant nervous stress at work, headaches and migraines caused by mental overload, as well as menopausal and premenstrual syndromes. In addition, this drug helps with functional disorders of the gastrointestinal tract and dermatological problems such as dermatitis, urticaria, seborrheic and atopic eczema.
Adults and children over 12 years can take the "Novopassit" 1 tablet or 1 teaspoonful of drug solution 3 times a day. The interval between meals single dosage should be at least 8 hours. If necessary, the daily dose may be doubled, and for digestive disorders (nausea) should drink "Novopassit" while eating. Also the drug should be taken 20-30 minutes before expected emotional stress.
Solution "Novopassit" children under 12 years can be given only after doctor's advice that make up an individual dose. So, to begin with child, it is recommended ½ tablet or ½ teaspoon of the solution once a day before bedtime. Contraindications to the drug are epilepsy, myasthenia gravis, hypersensitivity to the components of the "Novopassit", as well as lactase deficiency and galactosemia. People with diabetes must take medication under the supervision of your doctor. In addition, "Novopassit" are not recommended to take with medications, CNS depressants, or alcohol, as it amplifies their effect.
Due to the combined action of the components of the "Novopassit" it is difficult to conduct kinetic observations as accurately as possible to establish their influence on the human nervous system.
"Novopassit" care to give bedridden patients, since it significantly reduces intestinal motility, which leads to persistent constipation.